NFKB1 and acute monocytic leukemia: Published records have shown the anti-inflammatory properties of DHM, evidenced by the effective protection of human umbilical vein endothelial cells (HUVECs) damaged by fatty acids [18], DHM can also inhibit intracellular lipid accumulation in human acute monocytic leukemia cells (THP-1 cells) [19] and suppress the activation of the NF-κB signaling pathways and downstream pro-inflammatory cytokines in HeLa cells [13].